Rapamycin slows aging in mice
What this study shows
Answered a crucial objection: does rapamycin really slow AGING, or just prevent the cancers that kill mice? By showing slower age-related change across many tissues (heart, liver, tendon, activity), it argued for genuine slowing of aging. Honestly reported harms too - more cataracts and testicular degeneration - making it a balanced landmark, not hype.
At a glance
| Evidence type | A Animal model Marked A because it is an animal intervention or observation study measuring an organismal outcome (model: Genetically heterogeneous mice); the code names the system studied -- animal work can be rigorous and still not be human data. |
| Study type | 4 - Animal Study |
| Model system | Genetically heterogeneous mice |
| Journal | Aging Cell |
| Year | 2012 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1111/j.1474-9726.2012.00832.x · PMID 22587563 · Free full text (PMC3434687) |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Rapamycin |
| Target | mTOR |
| Model | Genetically heterogeneous mice |
| Effect | Rapamycin slows multiple aspects of aging (heart, liver, tendon, activity), beyond just suppressing cancer |
| Dose | 4.7, 14, or 42 ppm rapamycin in food, administered from age 9 months. |
| Sample size | Genetically heterogeneous mice; young (4 month) and old (20-22 month) control groups, and old mice treated with rapamycin at 4.7, 14, or 42 ppm; N varies by outcome (e.g., 15-80 per group). |
| Effect size | Rapamycin significantly reduced incidences of liver degeneration (P=0.02), myocardial nuclear abnormalities (P=0.047), endometrial hyperplasia (P=0.05), and adrenal tumors (P=0.04); however, it increased cataract severity (P=0.014 males, P=0.001 females) and testicular degeneration (P<0.001). |
| Limitations | Histological evaluation of cataracts was limited to a small number of specimens; site-to-site variation was considerable for spontaneous activity; some observed trends did not reach statistical significance. |
In the Atlas
Related topics
More studies on this topic
- Disruption of the insulin/IGF-1 signaling pathway in Caenorhabditis elegans dramatically increases male longevity and enhances reproductive health late in life (2026)
- Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice (2011)
- Intermittent Administration of Rapamycin Extends the Life Span of Female C57BL/6J Mice (2016)
- Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls (2014)
Was this page useful?
Thank you. Your answer was counted anonymously.